Podcast Categories: Crux of Cardio

In this episode of the Crux of Neuro, Liz Moyles is joined by Hubert Martens, physicist-turned-entrepreneur, co-founder of Sapiens Steering Brain Stimulation (acquired by Medtronic for ~$200M), and now CEO of Salvia BioElectronics. Hubert shares how a career that started with double-layer DVD technology at Philips led him to building a patient-centred neuromodulation implant for… Continue reading The Tricuspid Valve Was Forgotten for Decades. TRiCares Is Changing That with Ahmed Elmouelhi

In this episode, your host, Jordan Burgin, is joined by Vlastimil Hrabal, CEO and Co-Founder of Kardi AI, to unpack why a 24-hour Holter monitor the hospital gold standard misses most dangerous arrhythmias, and how long-term, AI-evaluated ECG monitoring is changing detection, prevention, and the economics of cardiac care.

In this episode of the Crux of Cardio, Jordan Burgin sits down with Dan Rose, CEO of Endovascular Engineering (E2), to talk about building, exiting, and doing it all over again this time in one of the hottest spaces in cardiovascular medicine. Dan joined LimFlow as its first employee, guided it through an FDA approval,… Continue reading We Had Seven Days of Cash Left with Dan Rose

In this episode, your host, Jordan Burgin, is joined by Brandon Allen a cardiovascular commercial leader who is CCO at Atraverse Medical, the transseptal-access company acquired by Johnson & Johnson to talk about what it really takes to commercialise cardiovascular technology. Drawing on two decades across Guidant, Boston Scientific, Biosense Webster, Acutus and Atraverse, Brandon… Continue reading The First Commercial Hire Makes or Breaks Your Startup with Brandon Allen

In this episode, your host, Jordan Burgin, is joined by Jim Hartman, Chief Commercial Officer at Cleerly, to talk about why heart disease is still caught too late and how AI-driven coronary CT analysis is moving diagnosis upstream, before the heart attack ever happens. Jim shares the personal story behind his switch from cardiac surgery… Continue reading Cleerly Is the Mammogram of the Heart with Jim Hartman

In this episode of the Crux of Cardio, your host Jordan Burgin sits down with Louis de Lillers, CEO of CorWave, the French company developing a next-generation LVAD powered by the wave membrane technology inspired by the motion of marine animals. Louis shares why current LVADs leave patients alive but without a pulse, and how… Continue reading The Himalaya of Medtech: Building a Next-Gen Heart Pump From Scratch with Louis de Lillers

In this episode of The Crux of Cardio, Jordan Burgin sits down with Ken Nelson, one of the most experienced commercial leaders in cardiac digital health. Ken helped scale commercial teams at iRhythm, BioTelemetry/CardioNet, and Bardy Diagnostics, three of the defining names in ambulatory cardiac monitoring. He shares the inside story behind the 2020–2021 cardiac… Continue reading Five Billion-Dollar Deals in 45 Days: Inside the Cardiac Monitoring Gold Rush with Ken Nelson

In this episode, your host Jordan Burgin sits down with Dr. Lucy O’Keeffe, CEO and Co-Founder of CroíValve, for the first ever in-person recording of the Crux of Cardio. Lucy explains why the tricuspid valve was once considered the “forgotten valve”, how her Dublin-based team is building a device that sits between repair and replacement,… Continue reading Half a Million Patients a Year and No Good Options, Until Now with Dr. Lucy O’Keeffe

In this episode of Crux of Cardio, Jordan Burgin sits down with Arnaud Mascarell, CEO and Co-Founder of FineHeart, the Bordeaux-based company behind the FlowMaker, a fully implantable cardiac assist device that works in synchrony with the heart’s natural contraction rather than replacing it. Arnaud shares the full journey: 18 years at Medtronic pioneering CRT… Continue reading The Heart Failure Industry Has It Wrong, This Tiny Turbine Could Fix It with Arnaud Mascarell

In this episode of the Crux of Cardio, Jordan Burgin sits down with Tarik Paćuka, former Chief Commercial Officer of Terumo Aortic, who scaled the business from a niche textile graft company into a $400M+ global cardiovascular player. Tarik shares the commercial playbook behind his 15-year rise from territory manager to CCO, the mentorship that… Continue reading From Territory Manager to CCO of a $400M Cardiovascular Powerhouse with Tarik Paćuka